|By PR Newswire||
|March 3, 2014 11:34 AM EST||
CLEVELAND, March 3, 2014 /PRNewswire-USNewswire/ -- Checkpoint Surgical has been awarded a contract for neural monitoring and nerve stimulation devices by the world's largest medical group purchasing organization MedAssets. The three year agreement between the two firms covers all Checkpoint devices and is effective April 1st, 2014. Checkpoint Surgical produces the Checkpoint Stimulator/Locator, which is a state-of-the-art, handheld, intra-operative nerve and muscle stimulator that helps surgeons locate, identify and evaluate motor nerve function in surgical procedures.
"We are pleased to announce this agreement," said Checkpoint CEO & President Len Cosentino. "We began this journey over 18 months ago and now to be officially recognized as a MedAssets' approved vendor is a significant accomplishment. It validates Checkpoint both clinically and financially as a device and a company and we look forward to helping MedAssets members save money while improving patient care."
About Checkpoint Surgical
2013 Manny award and Innovation in Business award-winning Checkpoint Surgical is headquartered in Cleveland, Ohio, a leading center for neurodevice research and development. Checkpoint Surgical provides surgeons with state-of-the-art neurodevices to locate and identify nerves and evaluate nerve and muscle function in surgical procedures.
SOURCE Checkpoint Surgical